Benes, Jan
Kotrc, Martin
Kroupova, Katerina
Wohlfahrt, Peter
Kovar, Jan
Franekova, Janka
Hegarova, Marketa
Hoskova, Lenka
Hoskova, Eva
Pelikanova, Terezie
Jarolim, Petr
Kautzner, Josef
Melenovsky, Vojtech
Funding for this research was provided by:
Ministerstvo Zdravotnictví Ceské Republiky (NV19-02-00130, NV 19-09-00125, IN 00023001)
Article History
Received: 20 February 2022
Accepted: 25 July 2022
First Online: 29 July 2022
Competing interests
: Josef Kautzner is a member of Advisory Boards for Bayer, Boehringer Ingelheim, Daiichi Sankyo, Biosense Webster, Medtronic and St Jude Medical (Abbott). He has received speaker honoraria from the above-mentioned companies and from Biotronik, Mylan, Pfizer and Pro Med. Petr Jarolim received research support from Abbott Laboratories, Amgen Inc., AstraZeneca LP, Beckman Coulter, Daiichi Sankyo, Inc., GlaxoSmithKline, Merck & Co., Inc., Roche Diagnostics Corporation, Takeda Global Research and Development Center and Waters Technologies Corporation and speaker honoraria from Roche Diagnostics Corporation. All other authors have no competing interest to declare.